
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事关于第四届董事会第十六次会议相关议案的独立意见 | 2023-08-16 | Chinese | |
| 关于延长公司向特定对象发行A股股票股东大会决议有效期及授权有效期的公告 | 2023-08-16 | Chinese | |
| 中德证券有限责任公司关于天域生态环境股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见 | 2023-08-16 | Chinese | |
| 关于归还募集资金及继续使用部分闲置募集资金暂时补充流动资金的公告 | 2023-08-16 | Chinese | |
| 关于召开2023年第四次临时股东大会的通知 | 2023-08-16 | Chinese | |
| 2023年第四次临时股东大会会议资料 | 2023-08-16 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38189365 | 独立董事关于第四届董事会第十六次会议相关议案的独立意见 | 2023-08-16 | Chinese | ||
| 38189344 | 关于延长公司向特定对象发行A股股票股东大会决议有效期及授权有效期的公告 | 2023-08-16 | Chinese | ||
| 38189327 | 中德证券有限责任公司关于天域生态环境股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见 | 2023-08-16 | Chinese | ||
| 38189311 | 关于归还募集资金及继续使用部分闲置募集资金暂时补充流动资金的公告 | 2023-08-16 | Chinese | ||
| 38189288 | 关于召开2023年第四次临时股东大会的通知 | 2023-08-16 | Chinese | ||
| 38189261 | 2023年第四次临时股东大会会议资料 | 2023-08-16 | Chinese | ||
| 38189248 | 关于公司办公地址变更的公告 | 2023-07-14 | Chinese | ||
| 38189230 | 关于公司2023年度对外担保预计的进展公告 | 2023-07-14 | Chinese | ||
| 38189214 | 2023年半年度业绩预告 | 2023-07-14 | Chinese | ||
| 38189207 | 关于公司2023年度对外担保预计的进展公告 | 2023-07-12 | Chinese | ||
| 38189197 | 关于参股公司签署《股权投资框架协议》的进展公告 | 2023-07-04 | Chinese | ||
| 38189182 | 关于2022年股票期权激励计划2023年第二季度自主行权结果暨股份变动的公告 | 2023-07-03 | Chinese | ||
| 38189170 | 关于天域生态环境股份有限公司2022年年度报告的信息披露监管工作函的回复 | 2023-06-27 | Chinese | ||
| 38189140 | 2022年年度报告(修订版) | 2023-06-27 | Chinese | ||
| 38189018 | 关于回复上海证券交易所监管工作函的公告 | 2023-06-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.